Skip to main content

Cornell University

3CPG

Cornell Center for Comparative and Population Genomics

News

March 20, 2025

Cornell bee experts are analyzing samples of bees and related material to help identify the cause of unprecedented managed honeybee losses this winter.

March 17, 2025

An FDA-approved drug used in humans has been found to inhibit the growth of oral squamous cell carcinomas in dogs - with one dog’s tumor nearly disappearing in a matter of weeks.

March 17, 2025

Students can choose from hundreds of courses in three-, six- and eight-week periods between June 2 and August 5 during Summer Session, 2025.

March 13, 2025

More than five years after a landmark study in the journal Science showed that North American bird populations declined by nearly 30% since 1970, a new report finds that the concerning trend is continuing apace.

March 13, 2025

When bats lose access to their habitat and natural food sources, they seek food on agricultural lands - new research explains why, when their diets change, they shed more virus and infect more hosts, increasing the risk of outbreaks and pandemics.

March 11, 2025

A new study using the largest network of microphones to track birds in the United States is providing crucial insights for managing and restoring fire-prone forests across California’s Sierra Nevada region.

March 10, 2025

William Boyle ’55, MBA ’56, has given a significant gift to the College of Agriculture and Life Sciences (CALS) to support renovations to the Plant Science Building.

March 7, 2025

Thirteen faculty members from across Cornell are being honored by the Einhorn Center for Community Engagement with this year’s Community-Engaged Practice and Innovation Awards. 

March 6, 2025

Researchers identified several families of "jumping genes," or transposons, in cyanobacteria and Streptomyces that can find and insert themselves at the telomere, with benefits for the transposon and their bacterial host. 

March 3, 2025

The new platform, which provided 100% protection from influenza and COVID-19 in mouse models, could vastly improve vaccine administration and the efficacy of the current flu vaccine.